(Q47609286)

English

Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

Women's attitudes toward preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French, and Canadian women (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

ovarian carcinoma

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

William David Foulkes

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

author name string

Julian-Reynier CM

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

Bouchard LJ

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

Eisinger FA

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

Kerr B

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

Blancquaert IR

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

Moatti JP

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

Sobol HH

9

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

language of work or name

0 references

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

92

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

959-968

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Variation in prophylactic surgery decisions

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Great expectations: historical perspectives on genetic breast cancer testing.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Geographic variation in the treatment of localized breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

A descriptive study of BRCA1 testing and reactions to disclosure of test results

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Four years analysis of cancer genetic clinics activity in France from 1994 to 1997: a survey on 801 patients. French Cooperative Network/Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C959%3A%3AAID-CNCR1406%3E3.0.CO%3B2-V

21 January 2018

Identifiers

10.1002/1097-0142(20010815)92:4<959::AID-CNCR1406>3.0.CO;2-V

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/11550171

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47609286&oldid=2162361031"